Aligos Therapeutics Inc. (ALGS) Stock Price

6.12 ▼ -0.79 (-11.43%)
Open: 6.64 Vol: 0 Day's range: 6.095 - 6.64 Aug 31, 13:04 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALGS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 6.11▲ 6.19▼ 6.36▼ 7.02▼ 6.44▼
MA10 6.23▼ 6.43▼ 6.67▼ 6.88▼ 5.84▲
MA20 6.43▼ 6.74▼ 6.95▼ 6.58▼ 5.78▲
MA50 6.91▼ 6.97▼ 6.91▼ 5.88▲ 7.41▼
MA100 6.90▼ 6.85▼ 6.89▼ 5.98▲ 11.06▼
MA200 6.83▼ 6.40▼ 5.83▲ 7.15▼ 16.47▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.010▼ -0.088▼ -0.125▼ -0.044▼ 0.247▲
RSI 26.174▼ 22.351▼ 25.014▼ 47.240▼ 48.517▼
STOCH 8.658▼ 11.684▼ 12.327▼ 54.129     56.553    
WILL %R -95.413▼ -97.537▼ -97.537▼ -98.462▼ -43.979    
CCI -65.957     -87.524     -145.452▼ -173.361▼ 54.023    
Latest Filters Detected On ALGS
RSI $ALGS RSI(14) Crossed Below 50 Set Alert
▼ MACD $ALGS MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ GAP $ALGS Open Gap Down %3 Set Alert
▼ GAP $ALGS Open Gap Down %2 Set Alert
▼ BREAK $ALGS Price Breaks 10 Days Low Set Alert
CDL $ALGS Marubozu Candlestick Pattern Detected Set Alert
Aligos Therapeutics Inc. News
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Wednesday, August 12, 2026 09:05 AM
ALG-170675 has been optimized for both HBsAg RNA inhibition and immuno-activationSingle and multiple ascending doses plannedStudy will allow rapid advancement into participants with chronic HBV ...
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
Monday, March 30, 2026 05:01 PM
SOUTH SAN FRANCISCO, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through ...
A Peek at Aligos Therapeutics's Future Earnings
Wednesday, March 04, 2026 07:02 AM
Aligos Therapeutics (NASDAQ:ALGS) is preparing to release its quarterly earnings on Thursday, 2026-03-05. Here's a brief overview of what investors should keep in mind before the announcement.
ALGS historical stock data
date open high low close volume
31/08/26 6.64 6.64 6.095 6.12 56,879
28/08/26 7.025 7.10 6.6401 6.91 39,065
27/08/26 7.44 7.495 6.8201 7.07 80,260
26/08/26 7.37 7.72 7.04 7.51 68,919
25/08/26 6.93 7.5377 6.85 7.47 92,560
24/08/26 6.575 6.99 6.42 6.96 28,753
21/08/26 6.48 6.7985 6.40 6.67 51,198
20/08/26 7.0055 7.0055 6.35 6.44 62,482
19/08/26 6.74 7.085 6.7008 6.89 77,135
18/08/26 6.50 6.84 6.4818 6.76 108,308
Quote Details
52wk Low:3.98
52wk High:13.689
Vol:0
Avg Vol(3m):3.5M
1Y Chng:-33.62%
1M Chng:+12.50%
Add to Watch List
More Information
Index US Composite
Market Cap. 44.15M